Painreform Market Capitalization from 2010 to 2024
| PRFX Stock | USD 2.85 0.31 9.81% |
Check Painreform financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Painreform's main balance sheet or income statement drivers, such as Interest Expense of 362.5 K, Tax Provision of 7.6 K or Depreciation And Amortization of 18.1 K, as well as many indicators such as Price To Sales Ratio of 982, Dividend Yield of 0.0 or PTB Ratio of 1.96. Painreform financial statements analysis is a perfect complement when working with Painreform Valuation or Volatility modules.
Painreform | Market Capitalization |
Latest Painreform's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Painreform over the last few years. It is Painreform's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Painreform's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.68 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Painreform Market Capitalization Regression Statistics
| Arithmetic Mean | 727,455,595 | |
| Geometric Mean | 548,458,950 | |
| Coefficient Of Variation | 57.79 | |
| Mean Deviation | 355,794,776 | |
| Median | 937,484,933 | |
| Standard Deviation | 420,409,739 | |
| Sample Variance | 176744.3T | |
| Range | 1.4B | |
| R-Value | (0.69) | |
| Mean Square Error | 100891.9T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | (64,443,391) | |
| Total Sum of Squares | 2474420.9T |
Painreform Market Capitalization History
About Painreform Financial Statements
Painreform investors use historical fundamental indicators, such as Painreform's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Painreform. Please read more on our technical analysis and fundamental analysis pages.
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel. Painreform is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.